This Year's Highlights

• A leading Midwestern health system uses the POINTONE Diabetes ChroniCare disease module to manage diabetes care for over 5000 patients. Its value to patient care and quality care initiatives has led to a 4th year renewal commitment.
• Since its release in mid-2006, the POINTONE Clinical Research System has been used at 3 institutions to manage laboratory, experimental and sample data for research studies supported by both public and private financing.
• The POINTONE Women?s Health Assessment is a featured component of one health system?s newly launched prevention and early detection initiative. The Women?s Health Assessment allows the hospital system to contact and recruit new patients.

Anticipated Highlights

• A major reference laboratory with $3.6 Billion in revenue plans to use POINTONE products in support of both a short-term product need and a long-term strategic partnership for improved reporting and understanding of translational medicine initiatives.
• A collaboration between POINTONE, a major Wisconsin health care provider and a leading molecular diagnostics company will shed light on how novel genetic tests will impact outcomes of patients undergoing warfarin therapy.
• A corporation whose vision is to shift health care?s focus from treatment to prevention will use POINTONE?s Risk Profile products to identify patients at risk for developing disease and to provide appropriate preventive screening and care.

Corporate Mission

POINTONE is the leader in the practical application of genetic and molecular knowledge to personalized health care. POINTONE?s products are a platform to translate medical discoveries to the right patients at the right time, while making these discoveries accessible to and usable by today?s health care providers. POINTONE?s disease-targeted knowledge management systems facilitate optimum patient care by integrating medical discoveries with best-practice standards of care.